Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of COLD-fX in the Prevention of Respiratory Infections in Community-dwelling Seniors: a Multi-center, Randomized, Double-blind, Placebo-controlled Trial

NCT00240461 is registered in ClinicalTrials.gov with Capital Health, Canada as lead sponsor.

NCT NCT00240461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00240461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of COLD-fX in the Prevention of Respiratory Infections in Community-dwelling Seniors: a Multi-center, Randomized, Double-blind, Placebo-controlled Trial
Lead sponsor
Capital Health, Canada
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2005
Completion date
December 31, 2008
Enrollment
780 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory tract infection